. Author manuscript; available in PMC: 2015 Mar 19.

Published in final edited form as: Pediatr Clin North Am. 2014 Oct 18;62(1):61–73. doi: 10.1016/j.pcl.2014.09.006

Table 1.

Outcomes for newly diagnosed childhood acute lymphoblastic leukemia

Cooperative Group	Study	Years	Patients	5-y EFS (%)
Berlin-Frankfurt-Münster⁵²	ALL-BFM-95	1995–2000	2169	79.6^a
Children’s Oncology Group⁵²	Multiple	2000–2005	7153	90.4
Dana Farber Cancer Institute Consortium⁵²	DFCI 95-01	1996–2001	491	82.0
Nordic Society of Pediatric Hematology and Oncology⁵²	NOPHO	2002–2007	1023	79.0
St Jude Children’s Research Hospital⁵²	TOTXV	2000–2007	498	85.6
United Kingdom Acute Lymphoblastic Leukaemia⁵²	UKALL 2003	2003–2011	3126	87.2

Abbreviation: EFS, event-free survival.

6-Year EFS used in ALL-BFM-95.